Company
Eton Pharmaceuticals Inc (NASDAQ:ETON)’s 12-Month Price Target Is Now Set At 15.
In last trading session, Eton Pharmaceuticals Inc (NASDAQ:ETON) saw 0.51 million shares changing hands with its beta currently measuring 1.28. Company’s recent per share price
